Om

C100 AB is a Swedish investment company focused on intellectual property-driven opportunities in the technology and life science sectors. The firm acquires, manages, and licenses portfolios of patents and related IP, targeting well-developed assets that can be commercialized or further developed with partners across the global market. Its activities center on identifying scalable technologies, structuring IP ownership, and supporting business development in underlying portfolio companies and platforms. Through this specialization, C100 AB serves as an intermediary between innovative IP creators and industrial or commercial operators that deploy these technologies in fields such as digital health, biotech platforms, and advanced software solutions. The company’s model positions it within the broader asset management and technology ecosystem, providing investors and counterparties access to curated intellectual property portfolios. C100 AB was founded in 2016 and is headquartered in Sweden, operating today as a dedicated IP-focused investment and management vehicle.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I C100 MED ENDAVU: Køb C100 ($V060) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i C100, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.